Hartford Financial Management’s Idexx Laboratories IDXX Stock Holding History

Hartford Financial Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.74K	Sell	9 -1	-10%	-$561	﹤0.01%	304
2026 Q1	$5.62K	Hold	10	–	–	﹤0.01%	289
2025 Q4	$6.77K	Hold	10	–	–	﹤0.01%	281
2025 Q3	$6.39K	Buy	10 +2	+25%	+$1.21K	﹤0.01%	286
2025 Q2	$4.29K	Hold	8	–	–	﹤0.01%	298
2025 Q1	$3.36K	Hold	8	–	–	﹤0.01%	317
2024 Q4	$3.31K	Hold	8	–	–	﹤0.01%	333
2024 Q3	$4.04K	Hold	8	–	–	﹤0.01%	332
2024 Q2	$3.9K	Hold	8	–	–	﹤0.01%	336
2024 Q1	$4.32K	Hold	8	–	–	﹤0.01%	333
2023 Q4	$4.44K	Buy	8 +2	+33%	+$939	﹤0.01%	337
2023 Q3	$2.62K	Hold	6	–	–	﹤0.01%	358
2023 Q2	$3.01K	Hold	6	–	–	﹤0.01%	329
2023 Q1	$3K	Hold	6	–	–	﹤0.01%	329
2022 Q4	$2.45K	Sell	6 -4	-40%	-$1.55K	﹤0.01%	338
2022 Q3	$3K	Hold	10	–	–	﹤0.01%	335
2022 Q2	$4K	Hold	10	–	–	﹤0.01%	330
2022 Q1	$5K	Buy	+10	New	+$5.26K	﹤0.01%	332

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Hartford Financial Management's IDXX Position: Q2 2026 in Review

Hartford Financial Management reduced its Idexx Laboratories (IDXX) stake by 10% in Q2 2026, selling an estimated $561 and leaving 9 shares worth $4.74K. The position accounts for ﹤0.01% of the portfolio, ranked #304.

Hartford Financial Management first reported a position in IDXX in Q1 2022 and has held it in 18 quarters since. The position peaked at $6.77K in Q4 2025. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

Hartford Financial Management held 9 shares of Idexx Laboratories worth $4.74K as of Q2 2026.
Hartford Financial Management sold 1 Idexx Laboratories share in Q2 2026, an estimated $561.
Idexx Laboratories made up ﹤0.01% of Hartford Financial Management's portfolio in Q2 2026, its #304 holding.
Hartford Financial Management first reported a position in Idexx Laboratories in Q1 2022 and has held it in 18 quarters since.
Hartford Financial Management's Idexx Laboratories position peaked at $6.77K in Q4 2025.
1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Hartford Financial Management's 13F filing for Q2 2026, filed 24 Jul 2026.